Litigation Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Docket		Date Filed	2017-04-07
Court	District Court, D. Delaware	Date Terminated	2020-07-28
Cause	35:271 Patent Infringement	Assigned To
Jury Demand	None	Referred To
Parties	PURDUE PHARMA L.P.
Patents	8,309,060; 9,060,976; 9,073,933; 9,492,389; 9,492,391; 9,522,919
Attorneys	Kenneth S. Canfield
Firms	Gibbons P.C.
Link to Docket	External link to docket

Details for Purdue Pharma L.P. v. Intellipharmaceutics International Inc. (D. Del. 2017)

Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2018-05-31	123	Notice of Service	. Wuts, Ph.D. on the Invalidity of U.S. Patents Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware	External link to document
2018-06-11	126	Notice of Service	, Ph.D. on the Non-Infringement of U.S. Patent Nos. 9,073,933 B2 and 9,522,919 B2 filed by Intellipharmaceutics…Non-Infringement of the Asserted Claims of the '993 and '919 Patents and Supplemental Expert Report of Neil E. Spingarn…Invalidity of the Asserted Claims of the '993 and '919 Patents; and (4) Rebuttal Expert Report of Peter G.M. Wuts…2017 28 July 2020 1:17-cv-00392 830 Patent None District Court, D. Delaware	External link to document
2018-07-06	130	Opinion - Memorandum Opinion	of multiple terms in U.S. Patent Nos. 9,060,976 ("the '976 patent"), 9,073 ,933 ("…construction for multiple terms in U.S. Patent Nos. 9,060,976, 9,073,933, 9,522,919, 9,492,389, and 9,…quot;the ' 933 patent"), 9,522,919 ("the ' 919 patent"), 9,492,389 ("the &… ' 389 patent"), and 9,492,391 ("the '391 patent"). The Court has considered…would infringe six of Plaintiffs' patents. (D.I. 1). The patents-in-suit relate to OxyContin®, an extended-release	External link to document